|Organ Transplant Diagnostics Market, 2031 - Emergence of Nucleic Acid Amplification Testing (NAAT) & Growing Focus on Molecular HLA Typing|
|By: PR Newswire Association LLC. - 25 Nov 2021||Back to overview list
DUBLIN, Nov. 25, 2021 /PRNewswire/ -- The "Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Transplant, Application, Technology, End User, and Region - Analysis and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
The global organ transplant diagnostics market is projected to reach $9,663.0 million by 2031, growing from $3,100.3 million in 2020, at a CAGR of 10.92% during the forecast period 2021-2031.
The market is driven by certain factors, which include rising number of organ transplant procedures, strategic initiatives by key market players, and favorable regulatory scenarios.
Currently, the organ transplant diagnostics industry is witnessing an upsurge due to the rising number of organ transplant procedures, strategic initiatives by key market players, and favorable regulatory scenarios are some of the critical factors which are expected to bolster the market growth.
Furthermore, biotechnology companies are focusing on the development of robust organ transplant diagnostics solutions for applications, including diagnostics and translational research, further supporting transplant physicians and researchers to unravel insights pertaining to the intricacies present in the field of transplant care. The development of organ transplant diagnostic products and services enabled transplant physicians to establish effective strategies for organ donor screening and recipient surveillance, further offering value-based care.
Within the research report, the market is segmented on the basis of offering, transplant, application, technology, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
The exponential rise in the number of organ transplant procedures worldwide has created a buzz among the biotechnology companies to further invest in the development of innovative organ transplant diagnostic tools, further aiding transplant physicians to offer value-based clinical outcomes to transplant patients. Due to the expansive product portfolio and massive geographical presence, Thermo Fisher Scientific Inc. has been the leading player in the organ transplant diagnostics ecosystem.
On the basis of region, North America holds the largest share of the organ transplant diagnostics market due to the presence of well-established guidelines regarding transplant diagnostics, presence of legacy companies undertaking key business strategies, rising number of organ transplants, and increasing adoption of products based on advanced molecular technologies by the transplant physicians, among others.
Further, increasing focus on research pertaining to the discovery of novel transplant-associated biomarkers is also expected to support the growth of the North America organ transplant diagnostics market. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period, 2021-2031.
Key Questions Answered in this Report:
Key Topics Covered:
2 Industry Insights
3 Market Dynamics
4 Competitive Landscape
5 Offering, $Million, 2020-2031
6 Transplant, $Million, 2020-2031
7 Application, $Million, 2020-2031
8 Technology, $Million, 2020-2031
9 End-User, $Million, 2020-2031
10 Regions, $Million, 2020-2031
11 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/febogl
Research and Markets
View original content:https://www.prnewswire.com/news-releases/organ-transplant-diagnostics-market-2031---emergence-of-nucleic-acid-amplification-testing-naat--growing-focus-on-molecular-hla-typing-301432082.html
SOURCE Research and Markets
Copyright 2021 PR Newswire Association LLC.
|Back to overview list|